NEW YORK TIMES: F.D.A. Approves the First New Schizophrenia Drug in Decades

F.D.A. Approves the First New Schizophrenia Drug in Decades





Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett from NYT (New York Times) Health
Read more.

Leave a Reply